Similarly, FOXP3 expression (Figure 2C) was significantly upregulated in expanded alloTregs from CKD patients (35,586 ± 20,391 vs. 7,986 ± 2,384, p < 0.05) and controls (27,390 ± 13,692 vs. 7,986 ± 2,384, p < 0.05). This evidence concerns the gene FOXP3 and chronic kidney disease.